Quantcast

Latest Biosimilar Stories

2014-04-22 12:27:06

Brazilian Public-Private Partnerships Drive Strong Growth in Biosimilars Pipeline, According to Findings from Decision Resources Group BURLINGTON, Mass., April 22, 2014 /PRNewswire/ -- Decision Resources Group finds that the number of publically disclosed biosimilar development projects has increased by more than 40 percent in the last 12 months. The majority of these development projects are yet to enter clinical development, but the 20 percent annual increase in the number of biosimilars in...

2014-04-15 08:29:42

DUBLIN, April 15, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today announced that it has entered into an agreement with Mylan Inc. and Famy Care Ltd. to settle all outstanding patent litigation related to Mylan's generic version of Generess(®) FE (norethindrone, ethinyl estradiol and ferrous fumarate chewable tablets). Under the terms of the agreement, Actavis will grant Mylan a license to market its generic version of Generess(®) FE under its pending Abbreviated New Drug...

2014-04-11 23:01:51

Transparency Market Research Report Added "Biosimilar And Follow-On Biologics Market - Global Industry Size, Share, Trends, Analysis And Forecasts 2012 - 2018" to its database. Browse Full Report - http://www.transparencymarketresearch.com/biosimilar-and-follow-on-biologics-market.html. Albany, New York, USA (PRWEB) April 11, 2014 There is a rising demand for low cost biological drugs. Commercial and regulatory developments are taking the follow-on biologics market to new...

2014-04-10 23:02:16

Transparency Market Research Report added "Global Biological Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" to its database. Browse full report: http://www.transparencymarketresearch.com/biological-drugs-market.html. (PRWEB) April 10, 2014 Biological drugs are biological medical products whose active drug substance is extracted by using living organism. The active substance is derived from living organism by the usage of...

2014-04-09 23:02:52

Transparency Market Research Report Added "Biosimilars Market - Global And China Forecast, Share, Size, Growth And Industry Analysis 2010 - 2017" to its database. Browse Full Report: http://www.transparencymarketresearch.com/biosimilars-market.html. Albany, New York USA (PRWEB) April 09, 2014 Biosimilars or follow-on biologics are copies of biological drugs (biopharmaceuticals). Biosimilars provide significant cost saving to both the users and the industry, hence the adoption of...

2014-04-08 23:02:54

New research report “Biosimilar Index: Tracking the Global Biosimilar Pipeline” worked out by FirstWord is now available at MarketPublishers.com London, UK (PRWEB) April 08, 2014 At present, biosimilars and non-comparable biologics (NCBs) are being developed across thirteen discreet therapy areas. There exist around 40 biosimilar and NCB programmes currently in Phase III trials. Moreover, it is known that there are fifteen biosimilar and NCB versions of bevacizumab (Avastin, Roche)...

2014-04-08 12:31:43

Three-Arm Phase I Trials are Being Used to Streamline Biosimilar Development, According to Findings from Decision Resources Group BURLINGTON, Mass., April 8, 2014 /PRNewswire/ -- Decision Resources Group finds that partnership activity in the biosimilar space increased 34 percent in 2013 compared with 2012. This increase was driven by biosimilar developers recognizing the need to augment their internal capabilities with those of an increasing number of market players looking to enter the...

2014-04-04 23:31:57

Development to Employ Catalent’s Leading GPEx® Cell Line Technology for Chinese Market Somerset, N.J. & Taizhou City, Zhejiang Province, China (PRWEB) April 03, 2014 Catalent Pharma Solutions, the leading global provider of development solutions and advanced delivery technologies for drug, biologic and consumer health products, today announced the signing of an agreement with Zhejiang HISUN Pharmaceuticals Co. Ltd. (HISUN), to provide HISUN with a broad range of biosimilar cell...

2014-04-03 12:30:06

LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Injectable Generic and Biosimilar Drugs - Potential Opportunities for Developers 2013 The market for injectable generics has been through a period of consolidation over the last few years as the leading companies have increased their presence through acquisition. The major players include Hospira, Sandoz (Novartis), Hikma Pharmaceuticals, Fresenius Kabi and Teva Pharmaceutical...

2014-04-03 08:29:16

DUBLIN, Apr. 03, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/m5wnkh/competitor ) has announced the addition of the "Competitor Analysis: Biosimilar and Biosuperior Therapeutic Antibodies" report to their offering. (Logo:http://photos.prnewswire.com/prnh/20130307/600769) The present Competitive Intelligence Report about Biosimilar and Biosuperior Therapeutic Antibodies 2014 provides a competitor evaluation in the field of recombinant monoclonal and...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related